BRADLEY FOSTER & SARGENT INC/CT

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1015086 HARTFORD, CT

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$406,691

+$8,655 QoQ

Shares Held

1,351

+12.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#506

of 780 holders

Holding Since

Dec 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRADLEY FOSTER & SARGENT INC/CT holds $1,337,687 across 4 Biotechnology names. ALNY ranks #2 (30.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,286	$638,794
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,351	$406,691
3	REGN	Regeneron Pharmaceuticals, Inc.	447	$278,722
4	CGTX	Cognition Therapeutics Inc	11,722	$13,480

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$406,691	1,351	+12.3%	Shares	Sole	2026-08-14
2026-03-31	$398,036	1,203	+71.6%	Shares	Sole	2026-05-15
2025-12-31	$278,752	701	+13.1%	Shares	Sole	2026-02-12
2025-09-30	$282,720	620	-88.1%	Shares	Sole	2025-11-10
2021-09-30	$986,154	5,223	0.0%	Shares	Sole	2021-11-10
2021-06-30	$885,402	5,223	-23.7%	Shares	Sole	2021-08-19
2021-03-31	$966,445	6,845	-33.5%	Shares	Sole	2021-04-26
2020-12-31	$1,338,431	10,298	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.